-
$0
0.0% of portfolio
-
Q2 2025
New
$1.96B
$24.9 Million
0.0% of portfolio
4,342,755
Q2 2025
Added 60.63%
$5.96B
$10.8 Million
0.0% of portfolio
515,350
Q2 2025
Reduced 1.78%
$777M
$10.9 Million
0.0% of portfolio
529,075
Q2 2025
Added 23.07%
$1.37B
$18.1 Million
0.0% of portfolio
2,235,534
Q2 2025
Added 138.54%
$66M
$80,000
0.0% of portfolio
27,186
Q2 2025
New
Amphastar Pharmaceuticals In
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.49B
$8.18 Million
0.0% of portfolio
356,250
Q2 2025
Reduced 12.41%
$143M
$390,000
0.0% of portfolio
122,104
Q2 2025
Added 22.91%
-
$0
0.0% of portfolio
-
Q2 2025
Added 6.79%
$0
$221,000
0.0% of portfolio
23,720
Q2 2025
New
$744M
$7.02 Million
0.0% of portfolio
566,093
Q2 2025
Added 19.56%
$885M
$2.27 Million
0.0% of portfolio
540,268
Q2 2025
Added 120.84%
-
$0
0.0% of portfolio
-
Q2 2025
New
$64.3M
$88,000
0.0% of portfolio
19,954
Q2 2025
Reduced 33.63%
$481M
$8.32 Million
0.0% of portfolio
1,297,982
Q2 2025
Reduced 35.2%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.26%
$840M
$2.71 Million
0.0% of portfolio
293,780
Q2 2025
Reduced 28.64%
$1.36B
$8.13 Million
0.0% of portfolio
221,090
Q2 2025
Added 0.49%
Andretti Acquisition Corp Ii
-
$0
0.0% of portfolio
-
Q4 2024
New
$61M
$16,000
0.0% of portfolio
11,600
Q2 2025
Reduced 75.81%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
$229M
$588,000
0.0% of portfolio
62,470
Q2 2025
Reduced 60.8%
-
$0
0.0% of portfolio
-
Q2 2025
Added 2,134.34%
$346M
$1.97 Million
0.0% of portfolio
198,670
Q2 2025
Reduced 23.36%
-
$0
0.0% of portfolio
-
Q2 2025
Added 23.97%
$1.54B
$13.4 Million
0.0% of portfolio
205,620
Q2 2025
Reduced 67.45%
$127M
$274,000
0.0% of portfolio
25,945
Q2 2025
Reduced 50.09%
Annaly Capital Management In
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 55.26%
$116M
$3.91 Million
0.0% of portfolio
1,630,649
Q2 2025
Added 93.76%
Anteris Technologies Global
-
$0
0.0% of portfolio
-
Q2 2025
Added 172.54%
$424M
$2.28 Million
0.0% of portfolio
88,857
Q2 2025
Reduced 28.75%
$645M
$7.48 Million
0.0% of portfolio
2,067,468
Q2 2025
Added 22.88%
$1.16B
$2.87 Million
0.0% of portfolio
331,257
Q2 2025
Reduced 37.46%
$2.63B
$3.74 Million
0.0% of portfolio
215,999
Q2 2025
Reduced 29.8%
$8.29B
$23.8 Million
0.0% of portfolio
466,774
Q2 2025
Added 162.06%
Apimeds Pharmaceuticals Us I
-
$0
0.0% of portfolio
-
Q2 2025
New
$961M
$3.86 Million
0.0% of portfolio
94,971
Q2 2025
Added 4.65%
-
$0
0.0% of portfolio
-
Q2 2025
Added 126.76%
$1.41B
$2.54 Million
0.0% of portfolio
262,404
Q2 2025
Reduced 39.46%
-
$0
0.0% of portfolio
-
Q1 2023
New
$5.5B
$15.8 Million
0.0% of portfolio
68,494
Q2 2025
Added 2.57%
$1.15B
$6.36 Million
0.0% of portfolio
213,074
Q2 2025
Reduced 44.76%
$2.79B
$34.1 Million
0.0% of portfolio
2,920,298
Q2 2025
Reduced 4.47%
$635M
$8.67 Million
0.0% of portfolio
337,327
Q2 2025
Added 83.88%
$21.1M
$226,000
0.0% of portfolio
730,718
Q2 2025
Added 131.07%
$9.12B
$15.2 Million
0.0% of portfolio
97,035
Q2 2025
Added 9.38%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 54.38%
$202M
$1.74 Million
0.0% of portfolio
524,685
Q2 2025
Reduced 35.92%